IL4 and neoplasm: Previous study has demonstrated that ILC2s secrete the characteristic cytokines IL-13 and IL-4, which facilitate tumor progression by facilitating the recruitment of monocyte-derived myeloid suppressor cells (MDSCs), which plays a crucial role in suppressing anti-tumor immune responses [27].